YHLO





NEWS：

YHLO launched its latest iFlash integrated system at CMEF, reaching new milestone with our persistence in R&D

 2021-10-21

The first shipment of YHLO iFlash 1200 to Latin America set sail

 2021-10-21

YHLO iFlash in top Chinese hospitals: Autoimmunity & Cardiovascular Diseases Cross-Field Academic Collaboration

 2021-10-09

YHLO initiates win-win cooperation with Beckman Coulter

 2021-08-18

New corner stone laid, the second biopark of YHLO began construction

 2021-10-20





About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575). As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to focus on healthcare, better life with technology.

Diagnostic for Human Health

Milestone

Corporate Values

Contact Us

MORE+

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +